NEW YORK (GenomeWeb News) – Agilent today reported 17 percent year-over-year revenue growth in its Life Science business unit for its fourth fiscal quarter, driven by a 40 percent boost in microarray sales.
 
For the three months ended Oct. 31, 2008, revenues for Agilent’s Life Science business, a division of its Bio-Analytical Measurement unit, rose 17 percent to $276 million. Revenue growth for this business was 10 percent excluding acquisitions.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.